MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients
about
Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.Prognostic Significance of Mucin Antigen MUC1 in Various Human Epithelial Cancers: A Meta-AnalysisMucins and toll-like receptors: kith and kin in infection and cancerMUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patientsPulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinomaCurrent status of mucins in the diagnosis and therapy of cancer.MUC1 contributes to BPDE-induced human bronchial epithelial cell transformation through facilitating EGFR activation.The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature.Expression and function of the protein tyrosine phosphatase receptor J (PTPRJ) in normal mammary epithelial cells and breast tumors.A signaling pathway consisting of miR-551b, catalase and MUC1 contributes to acquired apoptosis resistance and chemoresistance.Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells.MicroRNA-dependent regulation of transcription in non-small cell lung cancer.Gene expression profiling identifies clinically relevant subtypes of prostate cancer.MUC1 and MUC2 in pancreatic neoplasiaTransmembrane mucins as novel therapeutic targetsMUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling.MUC1 as a target antigen for cancer immunotherapy.Host response in tumor diagnosis and prognosis: importance of immunologists and pathologists allianceAntitumor effects of L-BLP25 antigen-specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model.MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression.Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non-small cell lung cancer (NSCLC).Maintenance and consolidation therapy in patients with unresectable stage III/IV non-small cell lung cancer.Mixed squamous cell and glandular papilloma of the lung: a case study and literature review.Emepepimut-S for non-small cell lung cancer.Glycomechanics of the metastatic cascade: tumor cell-endothelial cell interactions in the circulation.MUC1 immunotherapy is here to stay.TAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases.Therapeutic cancer vaccines in the treatment of non-small-cell lung cancer.Advanced technologies for studying circulating tumor cells at the protein level.Actual status of therapeutic vaccination in non-small cell lung cancerImmunotherapy for Lung Cancer: Has it Finally Arrived?Glycosylation alterations in lung and brain cancer.TG4010: a vaccine with a therapeutic role in cancer.Three to Tango: MUC1 as a Ligand for Both E-Selectin and ICAM-1 in the Breast Cancer Metastatic CascadeMUC1 in macrophage: contributions to cigarette smoke-induced lung cancer.Pivotal role of MUC1 glycosylation by cigarette smoke in modulating disruption of airway adherens junctions in vitroCigarette smoke induces epidermal growth factor receptor-dependent redistribution of apical MUC1 and junctional beta-catenin in polarized human airway epithelial cellsInteraction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in human epithelial cancer cells.Cigarette smoke disrupts the integrity of airway adherens junctions through the aberrant interaction of p120-catenin with the cytoplasmic tail of MUC1.Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance.
P2860
Q24810591-C942613B-A87F-42BE-BBC4-D01686A951D7Q26774725-0020EB7A-B0F1-473C-863A-72D76E11FC03Q26830597-870283E0-99D2-45A7-8CF5-62E269E36843Q33574955-EBC2DD0B-02AB-44E2-8844-C3A056A9F306Q33593905-C77537BA-F1EC-4FF7-84EB-373024187383Q33757326-FA5DEA9A-DEC0-4907-A9D8-DC181B503D35Q34212005-BCA66C2C-2A8A-4062-8629-D3BC9760C958Q34273106-96B9BA2C-43A7-4C51-AC1A-68F183F305FDQ34345106-1E0C6FEF-A489-4A12-850F-955CFB171B4CQ34434902-2F048CBA-3A4C-4F7A-B889-4E2B62596BAAQ34970672-347A5676-D26F-4D1B-99C1-9F3FD3788AF3Q35119983-AB51A5EB-69F6-4DC3-98D3-6682027EADE4Q35554359-1679EA2B-C5B9-4131-A60D-2E92C8E1ADF2Q35587636-7FC90051-B6AF-4F9C-A94F-832245FBD030Q35632645-80BBC170-E6EB-4E33-8C5A-5C17D2240160Q35635449-4255ED0C-40EC-4F8B-891F-C8AB79B0A46DQ36238699-A9F9D6FC-0E7F-4678-9921-3D88847B2D5FQ36457087-7C4E60AC-61BF-4345-87BB-7CA2EEE36A87Q36707865-5223D268-C444-42E2-8604-E54245B9C3A6Q37520973-E8C928E6-FF7D-4A26-AE39-EBFC78DEBFD1Q37663903-7E6F32D3-8058-43EC-9500-078D18035962Q37798621-11233536-0DAD-46F3-AD53-5439B11713B6Q37854865-A7745521-7D1C-4812-BA5C-0B0ECF4D29A6Q37891983-BAD49A97-6984-4113-A821-7ECC973602B2Q37958726-511256D8-FBDE-4CAC-8EEA-C92E9543F5A9Q38045428-750E1ABE-D71C-4144-90F2-872A4572A1CBQ38067267-1E17447B-A852-4514-A3AD-3BCAA79E05DFQ38089936-AB1E9FC6-6EC9-4BED-97E3-6133F6967948Q38160932-796AF851-4554-499D-90A9-EB9753996A7DQ38223388-851FB633-AFC4-45FB-8CD8-A4B544638657Q38265555-E88E6C63-A795-4DC0-9316-B810DF6D41F2Q38366332-7DF6095E-3093-47A7-AEEC-C56F1133D59FQ38824172-BF251840-770E-4DC6-A1C6-4F0F5E9AA681Q39301899-8700DD6E-E93B-4F3C-BD6A-A6E325C55CDBQ42071273-E1C7339C-67E4-47CF-B109-D571D62033FFQ42212778-28AAD0D6-E0C9-4D2B-9396-01ED911F9D52Q42470542-823193A6-86EA-4D4B-A23F-63CCED968883Q42706133-33740247-6633-4617-BFEF-497AD4C7AB35Q42734887-A91A9ADE-FDB3-463C-8A60-0EB79B9EA7B7Q43923444-C03366C7-AE78-488D-9787-147DA62DD0BE
P2860
MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1998
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MUC1 (episialin) expression in ...... ival in node positive patients
@en
MUC1
@nl
type
label
MUC1 (episialin) expression in ...... ival in node positive patients
@en
MUC1
@nl
prefLabel
MUC1 (episialin) expression in ...... ival in node positive patients
@en
MUC1
@nl
P2093
P2860
P356
P1476
MUC1 (episialin) expression in ...... ival in node positive patients
@en
P2093
Bonsignore G
Chlouverakis G
Giatromanolaki A
Koukourakis MI
Vignola AM
P2860
P304
P356
10.1136/JCP.51.9.667
P407
P577
1998-09-01T00:00:00Z